Jim Cramer Recently Discussed These 7 Stocks
Jim Cramer, host of Mad Money, recently addressed how investors can sometimes lose sight of the broader market perspective.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 2,664,162 | $1,345,987,926 | +1% | 5.32% |
| 2. | Millennium Management Israel Englander | 155,767 | $78,696,604 | +21% | 0.03% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 133,575 | $67,484,762 | +6% | 0.05% |
| 4. | D E Shaw D. E. Shaw | 126,215 | $63,766,342 | +388% | 0.05% |
| 5. | Point72 Asset Management Steve Cohen | 96,462 | $48,734,437 | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | Director | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | Director | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | Director | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | Director | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | Director | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $420.44 | 344 | Director | 905 | 2024-11-27 | Filing | |
| $469.37 | 500 | Director | 0 | 2024-09-06 | Filing | |
| $540.80 | 200 | Director | 161 | 2024-05-17 | Filing | |
| $559.33 | 680 | Officer | 10,711 | 2024-03-06 | Filing | |
| $558.88 | 3,290 | Officer | 11,391 | 2024-03-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,054,307 | $5,025,593,068 | 0.12% | |
| 2. | 8,377,667 | $4,650,024,068 | 0.1% | |
| 3. | 3,776,949 | $2,096,395,542 | 0.1% | |
| 4. | 2,937,760 | $1,630,603,688 | 0.62% | |
| 5. | 2,300,017 | $1,276,624,436 | 3.39% |
News See All
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Douglas Ott. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Third Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
Here's Why Aristotle Focus Growth Strategy Sold IDEXX Laboratories (IDXX)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S.
10 Best Pet Stocks To Invest In According to Analysts
The pet industry is a rapidly growing sector.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Analyzing Good Businesses’ Substack by YoungHamilton. In this article, we will summarize the bulls’ thesis on IDXX.
10 Best Quality Stocks to Buy According to Analysts
The stock market has seen a notable 20% increase year-to-date, but as it approaches the seasonally volatile months leading up to Election Day, potential volatility is expected.
Here’s Why IDEXX Laboratories (IDXX) Detracted in Q2
Baron Funds, an investment management company, released its “Baron Partners Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
Billionaire Hedge Funds
